1. Lumateperone in schizophrenia: a profile of its use

   • James E. Frampton

   Adis Drug Q&A 06 October 2020 Pages: 477 - 484

   

2. Upadacitinib in rheumatoid arthritis: a profile of its use

   • Sean Duggan
   • Susan J. Keam

   Adis Drug Q&A 26 October 2020 Pages: 485 - 493

3. Olopatadine/mometasone combination nasal spray in allergic rhinitis: a profile of its use

   • Yvette N. Lamb

   Adis Drug Q&A 27 September 2020 Pages: 494 - 501

   

4. Methadone is an option to treat cancer pain in carefully selected patients

   • Caroline Fenton
   • Katherine A. Lyseng-Williamson

   Disease Management 02 September 2020 Pages: 502 - 508

   

5. The role of renin–angiotensin–aldosterone system inhibition in the regression of hypertensive left ventricular hypertrophy: the evidence of the last three decades

   • Shah Newaz Ahmed
   • Ratinder Jhaj
   • Rajnish Joshi

   Therapy in Practice 27 August 2020 Pages: 509 - 517

6. Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers

   • Chia Siang Kow
   • Syed Shahzad Hasan

   Current Opinion 16 August 2020 Pages: 518 - 522

7. The COVID-19 pandemic threatens the Expanded Program on Immunization: recommendations for sustaining vaccination goals

   • Husnain Hamid
   • Tauqeer Hussain Mallhi
   • Noor ul Ain

   Commentary 05 September 2020 Pages: 523 - 525

   

8. Cosmetic disfigurement from black salve

   • Lopa Thambi
   • Karen Konkel
   • Lynda McCulley

   Commentary 26 September 2020 Pages: 526 - 528

   

9. Evaluation of the prescribing of proton pump inhibitors as stress ulcer prophylaxis for non-ICU patients in a Malaysian tertiary hospital

   • Muhammad Eid Akkawi
   • Mohamed Hassan Elnaem

   Original Research Article 31 August 2020 Pages: 529 - 534